Liang Z - Search Results

1

Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy.

Liu P, Yuan Y, Cui B, Huo Y, Bian L, Chen L, Liu S, Wang C, Xu Y, Tedcastle A, Gao F, Mao Q, Martin J, Liang Z. Liu P, et al. Among authors: liang z. Viruses. 2021 Apr 21;13(5):720. doi: 10.3390/v13050720. Viruses. 2021. PMID: 33919184 Free PMC article.

2

[Genetic characterization of enterovirus 71 complete genome isolated in Beijing, 2008].

Yao X, Mao QY, Huang WJ, He P, Zhou C, Zhang W, Liang ZL, Li FX, Wang JZ. Yao X, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Jul;30(7):729-32. Zhonghua Liu Xing Bing Xue Za Zhi. 2009. PMID: 19957602 Chinese.

3

Dynamic change of mother-source neutralizing antibodies against enterovirus 71 and coxsackievirus A16 in infants.

Mao QY, Liao XY, Yu X, Li N, Zhu FC, Zeng Y, Liang ZL, Li FX, Wang JZ, Lu FM, Zhuang H. Mao QY, et al. Chin Med J (Engl). 2010 Jul;123(13):1679-84. Chin Med J (Engl). 2010. PMID: 20819628

4

Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71.

Mao Q, Li N, Yu X, Yao X, Li F, Lu F, Zhuang H, Liang Z, Wang J. Mao Q, et al. Among authors: liang z. Arch Virol. 2012 Jan;157(1):37-41. doi: 10.1007/s00705-011-1136-3. Epub 2011 Oct 9. Arch Virol. 2012. PMID: 21984267

5

Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines.

Liang Z, Mao Q, Gao Q, Li X, Dong C, Yu X, Yao X, Li F, Yin W, Li Q, Shen X, Wang J. Liang Z, et al. Vaccine. 2011 Dec 6;29(52):9668-74. doi: 10.1016/j.vaccine.2011.10.018. Epub 2011 Oct 19. Vaccine. 2011. PMID: 22015395 Free article.

6

Enterovirus 71 viral capsid protein linear epitopes: identification and characterization.

Gao F, Wang YP, Mao QY, Yao X, Liu S, Li FX, Zhu FC, Yang JY, Liang ZL, Lu FM, Wang JZ. Gao F, et al. Virol J. 2012 Jan 20;9:26. doi: 10.1186/1743-422X-9-26. Virol J. 2012. PMID: 22264266 Free PMC article.

7

Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial.

Li YP, Liang ZL, Gao Q, Huang LR, Mao QY, Wen SQ, Liu Y, Yin WD, Li RC, Wang JZ. Li YP, et al. Vaccine. 2012 May 9;30(22):3295-303. doi: 10.1016/j.vaccine.2012.03.010. Epub 2012 Mar 15. Vaccine. 2012. PMID: 22426327 Clinical Trial.

8

Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants.

Zhu FC, Liang ZL, Meng FY, Zeng Y, Mao QY, Chu K, Song XF, Yao X, Li JX, Ji H, Zhang YJ, Li L, Pan HX, Xu K, Dai WM, Zhang WW, Deng F, Wang H, Wang JZ. Zhu FC, et al. PLoS One. 2012;7(5):e37206. doi: 10.1371/journal.pone.0037206. Epub 2012 May 25. PLoS One. 2012. PMID: 22662137 Free PMC article.

9

Reactogenicity and immunogenicity of an enterovirus 71 vaccine in Chinese healthy children and infants.

Zhu FC, Wang JZ, Li XL, Liang ZL, Ge HM, Meng FY, Mao QY, Zhang YT, Zhang ZY, Ji H, Gao F, Guo HJ, Zhu QY, Chu K, Wu X, Li JX, Chen QH, Chen XQ, Zhang WW, Hu YM, Li L, Li FX, Yao X, Liu P, Wang H, Shen XL. Zhu FC, et al. Pediatr Infect Dis J. 2012 Nov;31(11):1158-65. doi: 10.1097/INF.0b013e31826eba74. Pediatr Infect Dis J. 2012. PMID: 22926209 Clinical Trial.

10

A neonatal mouse model of coxsackievirus A16 for vaccine evaluation.

Mao Q, Wang Y, Gao R, Shao J, Yao X, Lang S, Wang C, Mao P, Liang Z, Wang J. Mao Q, et al. Among authors: liang z. J Virol. 2012 Nov;86(22):11967-76. doi: 10.1128/JVI.00902-12. Epub 2012 Sep 5. J Virol. 2012. PMID: 22951825 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,176 results

Search Page